Other non-routine biomarkers such as lipid fractions and glycan moieties regulated by HNF1A have been explored for distinguishing HNF1A from other diabetes subtypes, but these have added complexity and cost above clinical features71,72, without better informing whom to test for the greater yield of monogenic diabetes provided from large-gene panel testing. Here, HNF1A is linked to diabetes mellitus.